SEC Info - Centogene N.V. - ‘6-K’ for 12/6/19

SEC Info℠

Home

Help

Please Sign In

Centogene N.V. – ‘6-K’ for 12/6/19

On: Friday, 12/6/19, at 12:23pm ET · For: 12/6/19 · Accession #: 950103-19-16937 · File #: 1-39124

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/06/19  Centogene N.V.                    6-K        12/06/19    2:21K                                    Davis Polk & … LLP 01/FA

Current Report by a Foreign Issuer — Form 6-K — Rule 13a-16 / 15d-16
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Current Report by a Foreign Issuer                  HTML      9K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     11K

‘6-K’ — Current Report by a Foreign Issuer

This is an HTML Document rendered as filed. [ Alternative Formats ]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the date of December 6, 2019

Commission File Number 001-39124

Centogene N.V.
(Translation of registrant's name into English)

Am Strande 7
18055 Rostock

Germany
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ___

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Centogene N.V.

On December 6, 2019, Centogene N.V. issued a press release titled “CENTOGENE Expands Executive Leadership Team”.

A copy of the press release is attached hereto as Exhibit 99.1.

C: 2

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CENTOGENE N.V.

Date: December 6, 2019

	By:	/s/ *Richard Stoffelen*
		Name:	Richard Stoffelen
		Title:	Chief Financial Officer

Exhibit Index

Exhibit	Description of Exhibit

99.1	Press release dated December 6, 2019

Dates Referenced Herein

This ‘6-K’ Filing	Date	Other Filings

Filed on / For Period end:	12/6/19	None on these Dates
		List all Filings

↑Top

Filing Submission 0000950103-19-016937 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)